A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition

A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition

The gut microbiota is considered a key player modulating the efficacy of immune checkpoint inhibitor therapy. The study investigated the association between the response to anti-PD-1 therapy and the baseline gut microbiome in a Polish cohort of melanoma patients, alongside selected agents modifying...

Full description

Bibliographic Details
Main Authors: Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik-Schmidt, Łukasz Galus, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, Marcin Schmidt
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
microbiome
melanoma
immune checkpoint inhibitor
diet
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/21/5369

Internet

https://www.mdpi.com/2072-6694/14/21/5369

Similar Items